On-DNA β-hydroxysulfone structure compound, synthesis method and application thereof
By optimizing the reaction conditions, the photocatalytic reaction of oligonucleic acid-olefin compounds with sodium sulfinate and nitrobenzene was successfully improved, and the yield and DNA integrity of On-DNAβ-hydroxysulfone structural compounds were solved, and the existing The problems of non-replicability and low yield of the preparation process in the technology provide new methods and application prospects for the construction of DNA-encoded compound libraries.
Patent Information
- Application Number
- CN202410268143.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-09
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-03-09
AI Technical Summary
In the DNA-encoding chemical library, there are reaction conditions that cannot be replicated and unpredictable during the preparation of On-DNAβ-hydroxysulfone structural compounds, resulting in low yields and DNA damage, limiting the diversity and efficiency of the compound library.
By reacting oligonucleic acid-olefin compounds, sodium sulfinate, nitrobenzene and photocatalysts (such as acidic red 87/hydrochloric acid) under specific conditions, high yields of On-DNAβ-hydroxysulfone structural compounds are generated, and the reaction is optimized. Conditions include temperature, solvent and light time to improve conversion and DNA integrity.
The high yield (up to 99%) and DNA integrity of On-DNAβ-hydroxysulfone structural compounds were achieved, enriching the chemical reaction types of DNA-encoded compounds library, and providing new application prospects for drug development.
Smart Images

Figure CN118257005B_ABST
Abstract
Description
Technical Field
[0001] The present application belongs to the field of construction of lead compound library in medical research, and specifically relates to On-DNA β-hydroxysulfone structure compound and preparation method thereof. Background Art
[0002] The use of DNA-encoded chemical libraries (DELs) has rapidly become an effective strategy for discovering new small molecule active compounds against various protein targets, such as kinases, phosphatases, metalloenzymes, hydrolases, and protein-protein interaction receptors. At least two clinical drug candidates come from small molecule active compounds discovered through DEL screening studies. These DELs are usually made using split-merge technology during synthetic transformations, and each synthetic step is constructed with a specific DNA tag encoding, so that each small molecule in the library is covalently labeled with a unique DNA codon. In a typical DEL screening study, a purified soluble protein target with an affinity tag is mixed with the DEL compound library, and high-affinity compounds are enriched relative to low-affinity compounds through several rounds of panning. The final eluted portion is then amplified using PCR amplification technology and sequenced by high-throughput sequencing technology to reveal the structure of the chemical small molecules that constitute the eluted population. The highly enriched compound small molecules obtained above are then synthesized without encoding DNA, and their activity can be confirmed by conventional biological target assays. This process can be repeated many times to further refine the category of small molecule compounds. DEL technology has been continuously developed in the past 10 years, and some recent reports of DNA-encoded library screening based on active proteins and living cells have broadened the scope of this exciting technology. The development of new reactions compatible with DNA has enriched the construction space of various compounds with drug properties and promoted the construction of new DEL libraries. However, this reaction still has quantitative limitations.
[0003] β-Hydroxysulfone structure can be found in many common drug molecules, such as Bicalutamide, which is a non-steroidal androgen antagonist that competes with androgens for androgen receptors, blocks the cell's uptake of androgens, and inhibits the binding of androgens to target organs. This product forms a receptor complex after binding to androgen receptors, enters the cell nucleus, and binds to nuclear proteins, thereby inhibiting tumor cell growth. It can be used as a first-line drug for palliative treatment of advanced prostate cancer. SCH42427 and SSY726 are a class of antifungal drugs containing β-hydroxysulfone structure.
[0004] The diversity of chemical structures is an important reason why DELT can successfully screen for biologically active compounds. Some novel parent core compounds are synthesized through traditional organic chemical reactions. Then, the parent core compound is linked to oligonucleic acid to construct a library of gene-encoded compounds, which is the synthesis idea of many DELs. In addition, new chemical reactions can be discovered and developed directly on oligonucleic acids. Although this research team has many successful cases of discovering and developing new chemical reactions on oligonucleic acids, such as On-DNA sulfonyl imine compounds, oligonucleic acid-thiazolidine compounds, and On-DNA dihydrothiazole-thiazole compounds, due to different reaction types and different reaction conditions, the damage to DNA and the conversion rate are unreproducible and unpredictable, that is, the synthesis of each type of On-DNA compound has its own unique technical difficulties. For example, in the process of developing the preparation method of On-DNA β-hydroxysulfone structure compounds, some of the preferred conditions in other reaction types failed in this reaction, that is, we did not get the results we wanted. For this reason, this research team has carried out long-term and extensive experimental work on the construction of On-DNA β-hydroxysulfone structure compounds. Summary of the invention
[0005] The present application first provides an On-DNA β-hydroxysulfone structure compound, the On-DNA β-hydroxysulfone structure compound has the following structure Where R 1 , R 2 Selected from the following substituted or unsubstituted groups: any one of C1-C4 alkylene, C3-C6 cycloalkyl, aryl, heteroaryl or heteroaromatic ring; wherein the substituent is any one or more of halogen, C1-2 alkyl, cyano or any combination thereof. wherein the C3-C6 cycloalkyl is a C3-C6 saturated cycloalkyl; the aryl is a 6-membered aryl; the heteroaryl is a 5-6-membered heteroaryl; the heteroaromatic ring is a 6-membered heteroaromatic ring; the halogen is fluorine, chlorine or bromine.
[0006] Secondly, the present application provides a method for preparing a β-hydroxysulfone structure compound with a yield of up to 99%, the preparation method comprising the following reaction: Specifically, an oligonucleic acid-olefin compound (Formula 1) with a final concentration of 0.2 to 1.6 mmol / L, a sodium sulfinate reagent (Formula 2) with a final concentration of 120 to 360 mmol / L, nitrobenzene (Ph-NO2) with a final concentration of 40 to 120 mmol / L, a photocatalyst (Acid Red 87 / hydrochloric acid, wherein the final concentration of Acid Red 87 is 8 to 80 mmol / L, and the final concentration of hydrochloric acid is 4 to 160 mmol / L) and a solvent are mixed, and the mixture is oscillated and irradiated (blue-green light of 455 to 577 nm) at 25 to 70°C for 0.2 to 5 hours to be converted into an oligonucleic acid-β-hydroxysulfone structure compound (Formula 3).
[0007] In some embodiments, the final concentration of the oligonucleotide-olefin compound is 0.2 to 1.6 mmol / L; in a preferred embodiment, the final concentration of the oligonucleotide-olefin compound is 0.4 to 1.2 mmol / L; in a more preferred embodiment, the final concentration of the oligonucleotide-olefin compound is 0.7 to 0.9 mmol / L.
[0008] In some specific embodiments, the sodium sulfite used is generated in situ by the following reaction, and after the reaction is completed, the obtained sodium sulfite does not need to be purified and can be used in the next reaction. However, we must recognize that the efficacy of the DEL reaction depends largely on the range of commercially available reagents, and the sodium sulfinate reagent can also be purchased directly from the market. In some embodiments, the amount of the sodium sulfinate reagent is 120 to 360 mmol / L final concentration based on 1 equivalent of the oligonucleic acid-olefin compound; in a preferred embodiment, the amount of the sodium sulfinate reagent is 150 to 300 mmol / L final concentration; in a more preferred embodiment, the amount of the sodium sulfinate reagent is 200 to 280 mmol / L final concentration.
[0009] In some embodiments, with 1 equivalent of oligonucleotide-olefin compound as a reference, the amount of nitrobenzene (Ph-NO2) used is 40 to 120 mmol / L final concentration; in a preferred embodiment, the amount of Ph-NO2 used is 50 to 110 mmol / L final concentration; in a more preferred embodiment, the amount of Ph-NO2 used is 60 to 100 mmol / L final concentration.
[0010] In one embodiment, with 1 equivalent of the oligonucleic acid-olefin compound as a reference, the amount of nitrobenzene (Ph-NO2) used is 80 mmol / L final concentration.
[0011] In one embodiment, taking 1 equivalent of oligonucleic acid-olefin compound as a reference, the amount of Acid Red 87 in the photocatalyst (Acid Red 87 / hydrochloric acid) is 0-80 mmol / L final concentration, the amount of hydrochloric acid is 0-160 mmol / L final concentration, and the yield is 22%-93%; in a preferred embodiment, the amount of Acid Red 87 in the photocatalyst (Acid Red 87 / hydrochloric acid) is 8-80 mmol / L final concentration, and the hydrochloric acid equivalent is twice that of Acid Red 87, and the yield is 89%-93%; in a more preferred embodiment, the amount of Acid Red 87 in the photocatalyst (Acid Red 87 / hydrochloric acid) is 20-40 mmol / L final concentration, and the hydrochloric acid equivalent is twice that of Acid Red 87, that is, Acid Red 87 is 20-40 mmol / L final concentration, hydrochloric acid is 40-80 mmol / L final concentration, and the yield is 92%-93%.
[0012] In one embodiment, the solvent of the reaction is any one of water, methanol (MeOH), tetrahydrofuran (THF), 1,4-dioxane, N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA), dimethyl sulfoxide (DMSO) or a mixture thereof. In a preferred embodiment, the solvent of the reaction is a mixture of water and dimethyl sulfoxide; in a more preferred embodiment, the solvent of the reaction is a mixture of water and dimethyl sulfoxide and the total content of water is 80% of the total volume of the reaction system.
[0013] In some embodiments, the reaction temperature is 25°C, 35°C, 40°C, 60°C, or 70°C.
[0014] In some embodiments, the wavelength of the radiant light is 455 to 577 nanometers; in a preferred embodiment, the wavelength of the radiant light is 492 to 565 nanometers; in a more preferred embodiment, the wavelength of the radiant light is 520 to 550 nanometers.
[0015] In some embodiments, the reaction time is 0.2 to 5 hours; in a preferred embodiment, the reaction time is 0.4 to 3 hours; in a more preferred embodiment, the reaction time is 0.5 to 1.5 hours.
[0016] In the experiment on the effect of temperature on conversion rate, the inventors found that the conversion rate of On-DNA β-hydroxysulfone structure compound increased with the increase of temperature, but the conversion rate at a reaction temperature of 70°C was not significantly higher than that at 40°C. Taking into account the stability of DNA, energy saving and other conditions, the inventors believe that the reaction temperature of 35°C to 60°C is the optimal reaction condition.
[0017] It is well known to those skilled in the art that the solvent also has an effect on the reaction. Although the structures of the On-DNA β-hydroxysulfone structure compound covered by the present application are numerous, the inventors have found that when the reaction of synthesizing the On-DNA β-hydroxysulfone structure compound from oligonucleic acid-olefin compounds and sodium sulfinate reagent is carried out in a mixed solvent of DMSO, DMF and THF and water, the yield of the product is significantly higher than the yield obtained by the reaction in a mixed solvent of MeOH, DMA, and 1,4-Dioxane and water; and the effect of the volume ratio of organic solvent to water on the conversion rate of the On-DNA β-hydroxysulfone structure compound is 1:4>1:3>1:2>1:1.
[0018] In the experiment on the effect of substrate concentration on product yield, the inventors found that when the final concentration of oligonucleic acid-olefin compounds was in the range of 0.2 to 0.8 mmol / L, the conversion rate of On-DNA β-hydroxysulfone structure compounds increased with the increase of the final concentration of oligonucleic acid-olefin compounds; when the final concentration of oligonucleic acid-olefin compounds was in the range of 0.8 to 1.2 mmol / L, the conversion rate of On-DNA β-hydroxysulfone structure compounds decreased with the increase of the final concentration of oligonucleic acid-olefin compounds.
[0019] The inventors found in the above specific implementation process that when the molar ratio of Acid Red 87 to hydrochloric acid is in the range of 1:2 to 2:1, the conversion rate of the On-DNA β-hydroxysulfone structure compound is higher than that when the molar ratio of Acid Red 87 to hydrochloric acid is 1:4, and the conversion rate of the On-DNA β-hydroxysulfone structure compound is the highest when the molar ratio of Acid Red 87 to hydrochloric acid is 1:2;
[0020] When the molar ratio of Acid Red 87 to hydrochloric acid remained constant at 1:2, the conversion rate of On-DNA β-hydroxysulfone structure compound increased slightly with the increase of the total amount of Acid Red 87 and hydrochloric acid.
[0021] The catalytic reaction between Acid Red 87 and hydrochloric acid needs to be maintained in the presence of nitrobenzene. During the experiment, we found that without nitrobenzene, the conversion rate of On-DNA β-hydroxysulfone structure compound was only 2%.
[0022] Under conditions determined by substrate concentration, solvent, temperature and other influencing factors (e.g., temperature of 40 degrees Celsius, final concentration of oligonucleic acid-olefin compound of 0.8 mmol / L, sodium sulfinate of 240 mmol / L), without catalysts Acid Red 87 and hydrochloric acid, the conversion rate of On-DNA β-hydroxysulfone structure compound was only 22%.
[0023] Based on the above statements, the inventors believe that those skilled in the art can reproduce the technical solution of the present application and obtain the technical effects stated in the present application without creative work.
[0024] It is well known in the art that DNA must remain stable under certain conditions; the reaction used for the construction of a DNA-encoded compound library needs to have a higher yield. Under the reaction conditions of the present invention, the oligonucleic acid-β-hydroxysulfone structure compound not only has a high yield, but also has good DNA integrity in the oligonucleic acid-β-hydroxysulfone structure compound. The integrity of the oligonucleic acid-β-hydroxysulfone structure compound product obtained in the present invention can not only be confirmed from liquid chromatography-mass spectrometry, but also can be verified by performing the next step of DNA enzyme-catalyzed coupling reaction (please refer to the "spectrum of the product of the oligonucleic acid-β-hydroxysulfone structure compound after TagA is connected" data). The present invention enriches the types of chemical reactions for synthesizing encoded compound libraries on DNA, constructs a new β-hydroxysulfone structure for synthesizing DNA-encoded compound libraries, and has very good application prospects in lead drug development. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 : The structure of raw material HP-NH2;
[0026] Figure 2 : HPLC-MS / MS detection spectrum of HP-Linker-NHFmoc;
[0027] Figure 3 : HPLC-MS / MS detection spectrum of HP-Linker-NH2;
[0028] Figure 4-Figure 16 : Liquid chromatography-mass spectrometry of oligonucleic acid-olefin compound raw materials (1a-1y) in sequence;
[0029] Figure 17-Figure 29 : Liquid chromatography-mass spectrometry detection spectra of oligonucleic acid-β-hydroxysulfone structure compounds 3a-3y, respectively;
[0030] Figure 30-Figure 41 : Liquid chromatography-mass spectrometry detection spectra of oligonucleic acid-β-hydroxysulfone structure compounds 3aa-3av;
[0031] Fig.42 : Spectrum of the product after oligonucleic acid-β-hydroxysulfone structure compound was connected to TagA. DETAILED DESCRIPTION
[0032] There are many methods for synthesizing β-hydroxysulfone, including metal-catalyzed reaction, metal-free reaction, photocatalytic reaction and electrocatalytic reaction. After research, it was found that transition metal catalysis easily causes DNA damage. So we tried to start with the in-situ generation of sodium sulfinate reagent with sulfonyl chloride, and generate On-DNA β-hydroxysulfone structure compound from oligonucleic acid-olefin compounds and sodium sulfinate reagent under the catalysis of photocatalyst.
[0033] We must recognize that the efficacy of the DEL reaction depends largely on the range of commercially available reagents. In addition to being purchased directly from the market, the oligonucleic acid-olefin compounds and sodium sulfinate reagents used in this application can be directly generated in situ. The so-called in situ generation means that the reaction, for example, sodium sulfinate can be synthesized by sulfonyl chloride and does not require purification, and the crude reaction product directly participates in the photocatalytic reaction, which greatly improves the feasibility of achieving the diversity of DEL compounds.
[0034] The synthesis of sodium sulfinate from sulfonyl chloride has the following reaction equation: Other sodium sulfinates prepared according to this reaction equation will be partially presented in the following examples.
[0035] The in situ generation of oligonucleic acid-olefin compounds is relatively complex compared to sodium sulfinate, and the applicant will elaborate on them one by one later. All reagents can be obtained commercially unless otherwise specified.
[0036] Preparation Example Preparation of oligonucleic acid-olefin compounds
[0037] The oligonucleotide-olefin compound is first prepared from HP-NH2 (commercially available reagent) to HP-Linker-NHFmoc, and then from HP-Linker-NHFmoc to HP-Linker-NH2. In the third step, HP-Linker-NH2 is converted into the oligonucleotide-olefin compound.
[0038] Synthesis of oligonucleotide-Linker-NH2 raw material (HP-Linker-NH2) HP-Linker-NHFmoc was prepared from HP-NH2 (commercially available reagent) with the following reaction equation:
[0039]
[0040] Specifically, 100.0 nanomoles of HP-NH2 (the structure of HP-NH2 is as follows Figure 140.0 equivalents of the starting head fragment compound (commercial product) in DMSO solution (concentration: 200.0 mmol / L), 250.0 equivalents of sodium tetraborate (Na2B4O7) buffer solution at pH = 9.5 (concentration: 250.0 mmol / L), and 40.0 equivalents of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride (DMT-MM) aqueous solution (concentration: 200.0 mmol / L) were mixed, and the mixture was thoroughly mixed with a vortex oscillator. The above mixture was then added to the HP-NH2 solution, mixed evenly, and reacted at 4°C for 1 hour. After the reaction was completed, 10% of the total volume of 5.0 mol / L sodium chloride solution was added to the reaction solution. Then, continue to add anhydrous ethanol 3 times the total volume, shake evenly, and place the reaction solution in a -80°C refrigerator for 2 hours. After that, centrifuge at 4000.0rpm for half an hour and pour off the supernatant. The remaining precipitate is dissolved in deionized water to obtain a solution of HP-Linker-NHFmoc. The spectrum of HP-Linker-NHFmoc is detected by liquid chromatography-mass spectrometry. Figure 2 As shown, its molecular weight is 5406.
[0041] Preparation of HP-Linker-NH2 from HP-Linker-NHFmoc:
[0042]
[0043] 100.0 nanomoles of HP-Linker-NHFmoc were dissolved in deionized water to prepare 1 mmol / L (100.0 microliters, 100.0 nanomoles, 1.0 equivalent), and 36.0 microliters of 10% piperidine aqueous solution were added thereto. The two were mixed evenly and reacted at room temperature for 1 hour. After the reaction was completed, 10% of the total volume of 5.0 mol / L sodium chloride solution was added to the reaction solution. Then, 3 times the total volume of anhydrous ethanol was added, and after oscillation, the reaction was placed in a refrigerator at -80°C and frozen for 2 hours. After that, centrifuged at 4000.0rpm for half an hour, and the supernatant was poured out. The remaining precipitate was dissolved in deionized water to obtain a solution of oligonucleotide-Linker-NH2 (HP-Linker-NH2). The spectrum of HP-Linker-NH2 detected by liquid chromatography-mass spectrometry is shown in the figure Figure 3 As shown, its molecular weight is 5184.
[0044] Synthesis of oligonucleic acid-olefin compound raw material (1a) from HP-Linker-NH2
[0045]
[0046] Dissolve 50.0 nanomoles of HP-Linker-NH2 in deionized water to make 1 mmol / L (50.0 microliters, 1.0 equivalent). Mix 40.0 equivalents of acrylic acid (commercially available product) in DMSO solution (concentration: 200.0 mmol / L), 250.0 equivalents of sodium tetraborate (Na2B4O7) buffer solution with pH = 9.5 (concentration: 250.0 mmol / L), and 40.0 equivalents of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride (DMT-MM) aqueous solution (concentration: 200.0 mmol / L), and mix the mixture thoroughly with a vortex oscillator. Then add the above mixture to the HP-Linker-NH2 solution, mix well, and react at room temperature for 1 hour. After the reaction is completed, add 10% of the total volume of 5.0 mol / L sodium chloride solution to the reaction solution. Then, 3 times the total volume of anhydrous ethanol was added, and after oscillation, the reaction solution was placed in a -80°C refrigerator for 2 hours. After that, the reaction solution was centrifuged at 4000.0 rpm for half an hour, and the supernatant was discarded. The remaining precipitate was dissolved in deionized water to obtain a solution of 1a, whose molecular weight was 5238.6 and the yield was >99%.
[0047] The invention team of this application adopted the method for preparing raw material 1a to synthesize other oligonucleic acid-olefin compounds (1b-1y). The test results of 1a-1y are shown in Figure 4-16 .
[0048] Examples 1-24
[0049] Take the following reaction as an example to optimize the reaction conditions
[0050]
[0051] The specific reaction conditions and reaction results are shown in Table 1.
[0052] Table 1 By comparing Examples 1-4, we can see that when other conditions remain unchanged, the molar ratio of Acid Red 87 to hydrochloric acid is in the range of 1:2 to 2:1, the conversion rate of On-DNA β-hydroxysulfone structure compound 3o is higher than that when the molar ratio of Acid Red 87 to hydrochloric acid is 1:4, and the conversion rate of On-DNA β-hydroxysulfone structure compound 3o is the highest when the molar ratio of Acid Red 87 to hydrochloric acid is 1:2.
[0053] By comparing Examples 2 and 5-6, we can see that when other reaction conditions remain unchanged, the conversion rate of On-DNA β-hydroxysulfone structure compound 3o increases with increasing temperature, but the conversion rate at a reaction temperature of 70°C is not significantly higher than that at 40°C. Considering the stability of DNA, energy saving and other conditions, the inventors believe that the reaction temperature of 35°C to 60°C is the optimal reaction condition.
[0054] By comparing Example 2 with Examples 7-11, we can see that the effect of solvent on the conversion rate of On-DNA β-hydroxysulfone structure compound 3o is that the effects of mixed solvents of DMSO, DMF and THF with water are significantly better than those of mixed solvents of MeOH, DMA, and 1,4-Dioxane with water.
[0055] By comparing Examples 12-15, we can see that the effect of the volume ratio of organic solvent to water on the conversion rate of On-DNA β-hydroxysulfone structure compound 3o is 1:4>1:3>1:2>1:1.
[0056] By comparing Examples 15-19, we can see that when the final concentration of the oligonucleic acid-olefin compound is in the range of 0.2 to 0.8 mmol / L, the conversion rate of the On-DNA β-hydroxysulfone structure compound 3o increases with the increase of the final concentration of the oligonucleic acid-olefin compound; when the final concentration of the oligonucleic acid-olefin compound is in the range of 0.8 to 1.2 mmol / L, the conversion rate of the On-DNA β-hydroxysulfone structure compound 3o decreases with the increase of the final concentration of the oligonucleic acid-olefin compound.
[0057] By comparing Examples 17, 20-23, we can see that when other reaction conditions remain unchanged, especially when the molar ratio of Acid Red 87 to hydrochloric acid remains unchanged at 1:2, the conversion rate of On-DNA β-hydroxysulfone structure compound 3o increases slightly with the increase in the total amount of Acid Red 87 and hydrochloric acid; Example 23 compared with other examples shows that even under other favorable conditions (such as a temperature of 40 degrees Celsius, a final concentration of an oligonucleic acid-olefin compound of 0.8 mmol / L, and a sodium sulfinate of 240 mmol / L), without the catalyst Acid Red 87 and hydrochloric acid, the conversion rate of On-DNA β-hydroxysulfone structure compound 3o is only 22%.
[0058] Example 24 Compared with other examples, the catalytic effect of Acid Red 87 and hydrochloric acid needs to be maintained in the presence of nitrobenzene. During the experiment, we found that without nitrobenzene, the conversion rate of On-DNA β-hydroxysulfone structure compound 3o was only 2%.
[0059] Example 25 Synthesis of oligonucleic acid-β-hydroxysulfone structure compound (3a) using oligonucleic acid-olefin compound raw material (1a)
[0060]
[0061] Oligonucleic acid-olefin compound (1a, 10.0 nmol, 1.0 equivalent, 2.0 mmol / L aqueous solution, 5.0 μL, 0.8 mmol / L final concentration), 2w (600.0 mmol / L aqueous solution, 5.0 μL, 240.0 mmol / L final concentration), nitrobenzene (Ph-NO2, 2000.0 mmol / L dimethyl sulfoxide solution, 0.5 μL, 80.0 mmol / L final concentration) and photocatalyst (Acid Red 87 / hydrochloric acid, 1:2, premixed, 250.0 mmol / L dimethyl sulfoxide solution, 2.0 μL, Acid Red 87 is 40.0 mmol / L final concentration) were added to a 0.6 ml centrifuge tube. The mixture was thoroughly mixed by vortexing, and then shaken and irradiated (535 nm green light) at 40°C for 1 hour. After the reaction, 10% of the total volume of 5.0 mol / L sodium chloride solution and 3 times of anhydrous ethanol were added to the reaction solution, and after being shaken evenly, it was placed in a refrigerator at -80°C for 2 hours, and then high-speed refrigerated centrifugation (4°C, 12000 rpm, 15 minutes), the supernatant was poured out, and the remaining precipitate was the product oligonucleotide-β-hydroxysulfone structure compound (3a), which was detected by liquid chromatography-mass spectrometry, with a molecular weight of 5431.2 and a yield of 74%.
[0062] Embodiment 26-71
[0063] The difference from Example 25 is that oligonucleic acid-olefin compounds (1b-1y) are used as raw materials to react with different sodium sulfinate reagents (2a-2w) to synthesize other representative oligonucleic acid-β-hydroxysulfone structure compounds (3b-3y, 3aa-3av). The specific raw material structures are shown in Table 2. The test results of 3a-3y and 3aa-3av are shown in Figure 17-41 .
[0064] Table 2
[0065]
[0066]
[0067]
[0068]
[0069] Example 72 Integrity verification experiment of oligonucleic acid in the oligonucleic acid-β-hydroxysulfone structure compound of the present invention
[0070] Oligonucleic acid-β-hydroxysulfone structure compound 3o is linked with Tag A (short-chain oligonucleotide, the molecular weights of the two chains are 4064 and 5884 respectively): 1.0 nanomole 3o is dissolved in deionized water to prepare a 1.0 mmol / L solution (1.0 μL, 1.0 nanomole, 1.0 equivalent), and 1.2 equivalents of TagA (1.0 mmol / L aqueous solution, 1.2 μL), 1.0 μL 10×T4 DNA linking buffer solution and 0.5 μL T4 DNA linking enzyme are added thereto. Then the above solutions are mixed evenly and reacted at room temperature for 1 hour. After the reaction is completed, 10% of the total volume of 5.0 mol / L sodium chloride solution is added to the reaction solution, and then 3 times the total volume of anhydrous ethanol is added. After shaking evenly, the reaction is placed in a refrigerator at -80°C for 2 hours. After that, centrifuge at 4000 rpm for half an hour and pour off the supernatant. The remaining precipitate was dissolved in deionized water and the molecular weight of the product was confirmed by liquid chromatography-mass spectrometry. The molecular weight was 15419.3. The mass spectrometry results are shown in Fig.42 .
[0071] The results of LCMS analysis show that the oligonucleic acid-β-hydroxysulfone structure compound 3o can be successfully coupled with TagA. This shows that the DNA chain integrity of the oligonucleic acid-β-hydroxysulfone structure compound obtained by the synthesis method described in this application is good. The LCMS mass spectrum can accurately display its molecular weight, further confirming that its nucleotides are not damaged. Therefore, the reaction method in the present invention will not damage the basic structure and activity of DNA.
[0072] The applicant would like to explain that the above enumeration is only for example, because we can understand that even if each oligonucleic acid-olefin compound raw material is listed in the table, it can form different combinations with different sodium sulfinates, and therefore cannot be exhausted.
[0073] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.
Claims
1. A method for synthesizing an On-DNA β-hydroxysulfone structure compound, characterized in that: The synthesis method of the On-DNA β-hydroxysulfone structure compound comprises generating the On-DNA β-hydroxysulfone structure compound by reacting an oligonucleic acid-olefin compound with a sodium sulfinate reagent under the catalysis of a photocatalyst. The specific reaction equation is as follows: It is an oligonucleic acid-olefin compound; Formula 2 is a sodium sulfinate reagent, and Formula 3 is an On-DNA β-hydroxysulfone structure compound; the reaction temperature is 25-70°C; the reaction solvent is a mixed solvent of DMSO, DMF, THF and water; the final concentration of the oligonucleic acid-olefin compound is 0.2-1.6 mmol / L; the final concentration of the sodium sulfinate reagent is 120-360 mmol / L; the final concentration of nitrobenzene is 40-120 mmol / L; the acid red 87 / hydrochloric acid is a photocatalyst, wherein the final concentration of acid red 87 is 8-80 mmol / L, and the final concentration of hydrochloric acid is 4-160 mmol / L; Where R 1 , R 2 Selected from the following substituted or unsubstituted groups: any one of C1-C4 alkylene, C3-C6 cycloalkyl, aryl, heteroaryl or heteroaromatic ring; wherein the substituent is any one of halogen, C1-2 alkyl, cyano or any combination thereof; the aryl is a 6-membered aryl; the heteroaryl is a 5-6-membered heteroaryl; the heteroaromatic ring is a 6-membered heteroaromatic ring; the halogen is fluorine, chlorine or bromine.
2. The method for synthesizing the On-DNA β-hydroxysulfone structure compound according to claim 1, characterized in that: The reaction temperature is 35-60°C.
3. The method for synthesizing the On-DNA β-hydroxysulfone structure compound according to claim 1, characterized in that: The final concentration of the oligonucleic acid-olefin compound is 0.4-1.2 mmol / L.
4. The method for synthesizing the On-DNA β-hydroxysulfone structure compound according to claim 1, characterized in that: The final concentration of the sodium sulfinate reagent is 150-300 mmol / L.
5. The method for synthesizing the On-DNA β-hydroxysulfone structure compound according to claim 1, characterized in that: The final concentration of the nitrobenzene is 50-110 mmol / L.
6. The method for synthesizing the On-DNA β-hydroxysulfone structure compound according to claim 1, characterized in that: The final concentration of Acid Red 87 in the photocatalyst is 15-60 mmol / L, and the hydrochloric acid equivalent is twice that of Acid Red 87.
